Send us a textThis episode explores the rapid advancements in understanding and treating CMT SORD, highlighting community engagement and innovative research, particularly focusing on the potential of the drug Gavorstat. The scientific journey from gene discovery to clinical trial showcases the power of collaboration, emphasizing patient voices in shaping treatment success.• Discussion on what CMT SORD is and its symptoms • Overview of the SORD gene’s role in the disease • Insights into the drug Gavorstat and its mechanism • Updates on clinical trial results for Gavorstat • The importance of community support and advocacy • The role of the Hereditary Neuropathy Foundation • Implications of CMT SORD advancements for other types • Shift towards patient-reported outcomes in research • Reflections on the future of CMT treatment strategiesLearn more about SORD and Inspire Clinical TrialParticipate in Research Join GRIN Today!Register for the 2025 CMT Summit in Nashville on 4/24-26Thanks for listening! Learn more at hnf-cure.org and subscribe for more updates on CMT research and advancements.
No persons identified in this episode.
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster